Literature DB >> 3002320

Specific B lymphocytes efficiently pick up, process and present antigen to T cells.

A Lanzavecchia, S Bove.   

Abstract

To study the nature of the antigen bridge between specific B and T lymphocytes we have isolated from the same donor clones of human T cells and EBV-transformed B cells specific for tetanus toxoid (TT). We found that TT-specific B cells are extremely efficient in presenting TT (but not an unrelated antigen) to T cells, as they can trigger T cell proliferation in the presence of only 10(-12) M TT, a concentration that is approximately 10(4) times lower than that required for presentation by conventional antigen-presenting cells such as macrophages or non-specific B cells. The high avidity of the interaction between specific B and T cells is reflected by the resistance to inhibition by antibodies against the T4 antigen. Experiments with fixed and chloroquine-treated B cells show that the role of surface antibodies is limited to the uptake of antigen and that in order to obtain presentation, the antigen has to be internalized, processed and subsequently displayed on the cell surface, where it becomes available for T cell recognition in an MHC-restricted fashion.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3002320

Source DB:  PubMed          Journal:  Behring Inst Mitt        ISSN: 0301-0457


  17 in total

Review 1.  B effector cells in rheumatoid arthritis and experimental arthritis.

Authors:  Alison Finnegan; Susan Ashaye; Keith M Hamel
Journal:  Autoimmunity       Date:  2012-04-19       Impact factor: 2.815

Review 2.  Neurotrophins and B-cell malignancies.

Authors:  Jennifer Hillis; Michael O'Dwyer; Adrienne M Gorman
Journal:  Cell Mol Life Sci       Date:  2015-09-23       Impact factor: 9.261

Review 3.  B Lymphocytes in Rheumatoid Arthritis and the Effects of Anti-TNF-α Agents on B Lymphocytes: A Review of the Literature.

Authors:  Ozlem Pala; Alain Diaz; Bonnie B Blomberg; Daniela Frasca
Journal:  Clin Ther       Date:  2018-05-23       Impact factor: 3.393

4.  T cell hybridomas to study MHC-II restricted B-cell receptor-mediated antigen presentation by human B cells.

Authors:  Matthew B Bartley; David H Canaday
Journal:  J Immunol Methods       Date:  2011-05-19       Impact factor: 2.303

5.  Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1.

Authors:  J M Binley; P J Klasse; Y Cao; I Jones; M Markowitz; D D Ho; J P Moore
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

6.  The identification of HLA class II-restricted T cell epitopes to vaccinia virus membrane proteins.

Authors:  Richard B Kennedy; Gregory A Poland
Journal:  Virology       Date:  2010-10-18       Impact factor: 3.616

7.  Specific lysis of mycobacterial antigen-bearing macrophages by class II MHC-restricted polyclonal T cell lines in healthy donors or patients with tuberculosis.

Authors:  D S Kumararatne; A S Pithie; P Drysdale; J S Gaston; R Kiessling; P B Iles; C J Ellis; J Innes; R Wise
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

8.  Progression from IgD+ IgM+ to isotype-switched B cells is site specific during coronavirus-induced encephalomyelitis.

Authors:  Timothy W Phares; Krista D DiSano; Stephen A Stohlman; Cornelia C Bergmann
Journal:  J Virol       Date:  2014-05-28       Impact factor: 5.103

9.  Characterization of MHC-II antigen presentation by B cells and monocytes from older individuals.

Authors:  H L Clark; R Banks; L Jones; T R Hornick; P A Higgins; C J Burant; D H Canaday
Journal:  Clin Immunol       Date:  2012-06-24       Impact factor: 3.969

10.  The Primate EAE Model Points at EBV-Infected B Cells as a Preferential Therapy Target in Multiple Sclerosis.

Authors:  Bert A 't Hart; S Anwar Jagessar; Krista Haanstra; Ernst Verschoor; Jon D Laman; Yolanda S Kap
Journal:  Front Immunol       Date:  2013-06-13       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.